UK Biopharmaceutical Biz Raises $260M In Series C Funding
By Jade Martinez-Pogue · January 2, 2024, 6:01 PM EST
British biopharmaceutical company Apollo Therapeutics revealed Tuesday that it completed a second close of its Series C financing round last month, bringing the total amount raised in the funding round over...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login